Author:
Yu Guanzhen,Yu Wenlong,Jin Guangzhi,Xu Dongyun,Chen Ying,Xia Tian,Yu Allan,Fang Wenzheng,Zhang Xiaoli,Li Zhaosheng,Xie Keping
Funder
G. S. Hogan Gastrointestinal Research Fund
Shanghai Pujiang Program
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine
Reference45 articles.
1. Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobil Surg Nutr. 2014;3(1):18–34.
2. Berardi R, Mocchegiani F, Pierantoni C, Federici A, Nicolini D, Morgese F, et al. Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome. Dig Liver Dis. 2013;45(1):70–4.
3. Juntermanns B, Radunz S, Heuer M, Hertel S, Reis H, Neuhaus JP, et al. Tumor markers as a diagnostic key for hilar cholangiocarcinoma. Eur J Med Res. 2010;15(8):357–61.
4. Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W, et al. The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma. Oncotarget. 2015;6(24):20419–33.
5. Bensinger SJ, Christofk HR. New aspects of the Warburg effect in cancer cell biology. Semin Cell Dev Biol. 2012;23(4):352–61.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献